Melanoma-associated mRNA markers (MAGE-3, MART-1, and tyrosinase) could be detected by RT-PCR in approximately 50% of patients with melanoma who developed IMD during the follow-up period [92]. This evidence concerns the gene MAGEA3 and melanoma.